rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

AIM ImmunoTech Inc.

AIM · NYSE American

Health CareBiotechnology

We hold no 150-day reading for AIM yet: it needs about 200 sessions of history. Biotechnology: 18% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
not in the set
Weeks in an uptrend
—
Industry in uptrend
18% -9 in 4 wk
Insider buys, 12 months
$27K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
15 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 0 weeks.

23 Apr – 22 Oct
18%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$122KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months0
Buyers · sellers1 · 0
WhoDidSharesTraded
Thomas K. EquelsCEO & Presidentbought24,000at $0.20817 Sep 2026filed 18 Sep 2026
Thomas K. EquelsCEO & Presidentbought11,000at $0.2116 Sep 2026filed 17 Sep 2026
Thomas K. EquelsCEO & Presidentbought22,000at $0.22115 Sep 2026filed 16 Sep 2026
Thomas K. EquelsCEO & Presidentbought5,900at $0.21914 Sep 2026filed 15 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders15+0 on the quarter
New · exited4 · 1
Reported value$291K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JANE STREET GROUP, LLCadded · filed 14 Aug 2026807,885$229K+787,838+3930.0%
MORGAN STANLEYadded · filed 13 Aug 202650,864$14K+50,000+5787.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202646,003$13K+16,085+53.8%
GOLDMAN SACHS GROUP INCnew · filed 14 Aug 202632,444$9,214+32,444
UBS Group AGadded · filed 13 Aug 202628,931$8,216+28,930+2893000.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLPnew · filed 14 Aug 202621,859$6,208+21,859
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202617,519$4,97500.0%
Ground Swell Capital, LLCnew · filed 5 Aug 202612,222$3,471+12,222
Tower Research Capital LLC (TRC)unchanged · filed 11 Aug 20264,668$1,32600.0%
Continuum Advisory, LLCnew · filed 6 Aug 2026500$142+500
30 Jun 2025 – 30 Jun 2026
111315Jun 25Sep 25Dec 25Mar 26Jun 26

News

Everyone who traded it

Thomas K. Equels Company insiderCEO & President · last 17 Sep 202658 · 0
David I. Chemerow Company insiderDirector · last 12 Mar 20260 · 0
Ted D. Kellner Company insiderDirector · last 11 Apr 20251 · 0
William M. Mitchell Company insiderDirector · last 11 Apr 20253 · 1
Peter W. Rodino III Company insiderCOO, Secretary, Gen. Counsel · last 4 Apr 20256 · 0
Nancy Bryan Company insiderDirector · last 14 Mar 20251 · 0
Stewart Appelrouth Company insiderDirector · last 31 Dec 202410 · 0
Ellen M. Lintal Company insiderChief Financial Officer · last 3 Mar 20220 · 0
David R. Strayer Company insiderChief Science/Medical Officer · last 21 Jun 20199 · 2
Wayne S. Springate Company insiderSr. VP of Operations · last 21 Jun 20197 · 1
Adam Pascale Company insiderCFO · last 8 May 20193 · 0
Iraj Eqhbal Kiani Company insiderDirector · last 30 Jun 20160 · 0

Same industry

No other stock in its industry this week.

Government contracts

No federal award is tied to it.

From its SEC filings

Interest coverFY 2025 · to 31 Dec 2025-14.36×
Share count trendFY 2025 · to 25 Mar 2026165%
Cash and equivalentsFY 2025 · to 31 Dec 2025$3.0M

Analyst forecasts

No analyst forecasts yet.